Kester Capital

Kester Capital LLP is a private equity firm based in London, United Kingdom, founded in 2007. The firm specializes in recapitalizations, buyouts, acquisitions, industry consolidation, and growth capital, primarily targeting lower middle market investments and small to medium enterprises (SMEs) seeking institutional capital for the first time. Kester Capital focuses on various sectors, including leisure, business and financial services, consumer electronics, application software, technology, media, telecommunications, hardware and equipment, services, niche markets, and healthcare. The firm typically invests between £5 million and £25 million, with a maximum investment limit of £40 million. Kester Capital aims to engage in controlling, majority, or influential minority investments, primarily within companies that have enterprise values ranging from £10 million to £250 million. The firm invests its own capital and operates primarily in the United Kingdom and Europe.

Joe Carpenter

Associate

Sophie Corrodi

Associate

Daisy Driscoll

Associate

David Fernie

Vice President

Patricia Hamel

COO

Robert Henderson

Vice President

Abhishek Majumdar

Partner

Murphy, Jack

Associate

Niehaus, Robert Henry

Chairman

Peter Ralph

Partner

Cam Steele

Vice President

Ben Woolley

Principal

23 past transactions

Re-Flow

Private Equity Round in 2025
Re-Flow is a Devon-based company specializing in field management software tailored for the construction, highways, traffic management, civil engineering, rail, and landscaping sectors. The software offers a range of features designed to streamline field operations, including the creation of digital job packs that can incorporate relevant PDF documents. Users can schedule events, assign operatives, and update work details in real-time through a user-friendly dashboard, with changes synchronized to a mobile app. The platform also allows for the development of customizable forms that meet regulatory requirements, promoting compliance and facilitating automated workflows. With over 180 firms utilizing its software, including notable industry players, Re-Flow helps organizations enhance efficiency and eliminate operational roadblocks, thereby advancing their field management capabilities.

Emas Pharma

Acquisition in 2024
Emas Pharma provides pharmaceutical and device development services worldwide and specializes in partnering with specialist pharma and biotech companies. Emas has in-depth expertise in complex small early phase and large global pivotal studies and all the regulatory and drug safety implications. Emas works as part of the client team and its expert team will stay on your project. Emas continues to partner right the way through the product lifecycle by providing medical affairs and medical information support, clinical services for post-marketing commitments and continued pharmacovigilance capability. Emas Pharma provides services globally through its offices in USA, Canada, Ireland, Australia and the UK and can deliver high quality full-service drug development solutions whilst retaining flexibility and delivering value.

GXP Engaged Auditing Services

Acquisition in 2023
GXP Engaged Auditing Services is an accounting and auditing firm that provides QM auditing and consultancy services.

MAP Patient Access

Acquisition in 2023
MAP Patient Access is a consulting firm that specializes in market access services for the pharmaceutical and biotech sectors. The company assists clients with various aspects of healthcare reimbursement processes, offering expertise in early engagement, pricing strategy, health economics, outcomes research, and evidence communication. By providing these tailored services, MAP Patient Access helps its customers effectively navigate the complexities of the global healthcare landscape.

DC Byte

Acquisition in 2022
DC Byte operates a data and analytics platform designed for the data center sector. It offers a comprehensive view of the market, encompassing both colocation and self-build enterprise assets. The platform integrates user-generated data from data center operators alongside proprietary research, ensuring that the information is continually updated and validated in real-time. This approach enables clients to access a broad range of insights, from global overviews to detailed analytics, supporting informed decision-making within the industry.

Optibrium

Private Equity Round in 2022
Optibrium is a software company specializing in solutions for small molecule design, optimization, and data analysis to enhance the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an office in Boston, US, Optibrium's flagship product, StarDrop, provides an integrated suite of tools featuring a user-friendly interface that facilitates the transition from data collection to predictive modeling and decision-making. This software aids researchers in determining the next steps in synthesis and investigation, ultimately increasing the efficiency and productivity of their work. The company collaborates closely with a diverse clientele, including major pharmaceutical, agrochemical, and flavoring firms, as well as biotechnology and academic institutions, to continuously develop new products and innovative technologies that streamline the discovery process.

Rephine

Acquisition in 2021
Rephine is an audit and consultancy company supporting the pharma industry in achieving compliance with all applicable good practices.

Optibrium

Private Equity Round in 2021
Optibrium is a software company specializing in solutions for small molecule design, optimization, and data analysis to enhance the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an office in Boston, US, Optibrium's flagship product, StarDrop, provides an integrated suite of tools featuring a user-friendly interface that facilitates the transition from data collection to predictive modeling and decision-making. This software aids researchers in determining the next steps in synthesis and investigation, ultimately increasing the efficiency and productivity of their work. The company collaborates closely with a diverse clientele, including major pharmaceutical, agrochemical, and flavoring firms, as well as biotechnology and academic institutions, to continuously develop new products and innovative technologies that streamline the discovery process.

You Garden

Acquisition in 2019
You Garden Limited, founded in 2011, is based in Kings Lynn, United Kingdom. The company specializes in the online sale of a wide range of gardening products, including flowers, trees, shrubs, fruits, vegetables, and gardening machinery. Additionally, You Garden offers various gifts for gardening enthusiasts, catering to the diverse needs of its customers.

ComplianceOnline

Acquisition in 2019
ComplianceOnline is the provider of legal, regulatory and business intelligence for the gambling and payments industries. We specialise in providing high level and independent insights, analysis, data and research through our primary services GamblingCompliance and PaymentsCompliance. Through our advanced web-based technology platform we provide industry professionals with the critical information they need to understand what regulatory change today means for the business opportunities of tomorrow. We pride ourselves on providing the most comprehensive, accurate and up-­to-­date information services and eLearning courses. Based in London, Washington, D.C., California and Taipei, ComplianceOnlines’s team of in-house analysts and journalists boast an unrivaled network of contacts among policymakers, lobbyists and legal experts, as well as a wealth of experience to analyse what regulatory change and market developments today, means for business opportunities tomorrow. Our clients include global law firms and legal professionals, regulators, advisory communities, online and terrestrial operators, lotteries, financial institutions, fintech and start-up companies, and payment technology and service providers. Learn more at: https://gamblingcompliance.com/ https://paymentscompliance.com/

VIXIO Regulatory Intelligence

Private Equity Round in 2019
VIXIO Regulatory Intelligence specializes in providing independent and authoritative insights into the complex landscape of regulatory developments, particularly in the payments and gambling sectors. The company offers a comprehensive platform that delivers in-depth news, legal analysis, and market commentary, catering to a diverse clientele that includes operators, regulators, technology providers, and law firms. By equipping regulatory and legal teams with actionable intelligence, VIXIO enables businesses to navigate regulatory risks effectively and identify new market opportunities. With a commitment to clarity and reliability, VIXIO stands as a trusted resource for organizations seeking to make informed decisions in a rapidly evolving regulatory environment.

CETA Insurance

Acquisition in 2017
CETA Insurance is a provider of personal and commercial insurance distribution services in the United Kingdom. The company specializes in offering a wide range of insurance products from leading insurers, utilizing a tech-enabled online broking platform. CETA facilitates the insurance process for companies by supplying tools for quoting, selling, and processing business, along with an introducer scheme and website facilities that allow partners to earn revenue without the burden of direct sales. By leveraging strong digital marketing strategies and deep data insights, CETA has established a significant presence in its core markets, fostering recurring customer relationships and enhancing its distribution channels.

Avania

Private Equity Round in 2016
Avania is a full-service contract research organization dedicated to managing clinical studies for a range of products, including medical devices, in vitro diagnostics, biologics, and combination products. The company specializes in providing tailored contract research services specifically for the medical device sector, guiding clients through all phases of product development, from feasibility studies to post-approval trials. Avania's expertise encompasses advanced technologies and novel products, enabling it to offer customized and scalable solutions that enhance operational efficiencies and facilitate the progression of medical technology on an international scale.

Frontier Medical Group

Private Equity Round in 2013
Frontier Medical Group is a prominent supplier of consumable products and services to healthcare providers, operating in the UK, Europe, and internationally. The company specializes in manufacturing pressure area care and infection control products, which include sharps disposal containers, clinical waste disposal containers, and harm reduction products. By focusing on these essential healthcare solutions, Frontier Medical Group supports the safe and effective management of healthcare environments.

Garrets International

Acquisition in 2012
Garrets International provides outsourced marine catering management for the commercial shipping industry. Garrets manages approximately 1000 vessels on behalf of some of the largest names in world shipping.

AgriBriefing

Acquisition in 2012
AgriBriefing is a business media company that specializes in pricing, data, marketing solutions, news, market intelligence, and insight. The business began with the launch of TheMediaBriefing - which provides strategic insight and market intelligence for senior decision makers in the global media industry - but expanded significantly in 2012 with the private equity-backed acquisition of Farmers Guardian and Pulse from UBM. Further acquisitions of LAMMA (the U.K.'s leading agricultural equipment and services exhibition) and Agrimoney (an award-winning intelligence portal covering the world of international agribusiness) followed alongside the sale of the Pulse healthcare business to Cogora Ltd. In July 2015 Briefing Media entered into a new financing agreement with Lyceum Capital Partners to support our continued growth. The company currently operates in the media strategy and agriculture industries (where we reach around 250,000 farming decision makers across our expanding range of products and services). AgriBriefing was founded in 2010 by seasoned media executives Neil Thackray & Rory Brown and is headquartered in London, UK.

Industry Dynamics

Private Equity Round in 2011
Industry Dynamics is a business-to-business events organizer that specializes in medium and large-scale events across Europe and North America. The company provides a diverse array of services, including training and online lead generation, catering to key sectors such as energy, pharmaceuticals, food and beverage, supply chain, and business services. By focusing on these verticals, Industry Dynamics aims to facilitate networking and knowledge sharing among professionals in various industries.

Chiltern International

Acquisition in 2010
Chiltern International Limited, a contract research organization, provides clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies.

Chiltern International

Private Equity Round in 2010
Chiltern International Limited, a contract research organization, provides clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies.

Travel Entertainment Group, Ltd.

Private Equity Round in 2008
Travel Entertainment Group, Ltd. provides entertainment services to the airline industry.

Ironshore Insurance

Private Equity Round in 2007
Ironshore Insurance, established in 2006 and headquartered in Hamilton, Bermuda, specializes in providing commercial property and casualty insurance products globally, including in the United States and Bermuda. The company offers a diverse range of coverages, such as professional and management liability, environmental and specialty casualty insurance, aviation, political risk, and surety products. Additionally, Ironshore caters to specific sectors including real estate, hospitality, and energy, while also underwriting catastrophic excess casualty and healthcare insurance. Certain specialty coverages are underwritten at Lloyd’s through Ironshore’s Pembroke Syndicate 4000. The company is recognized for its strong financial standing, holding an A (Excellent) rating from A.M. Best. Ironshore operates primarily in the wholesale market, focusing on complex and unique risks, and is committed to delivering customized insurance solutions and improved claims outcomes. As of May 2017, Ironshore operates as a subsidiary of Liberty Mutual Group.

Xanthus Pharmaceuticals

Series B in 2006
Xanthus Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the discovery, development, acquisition, and commercialization of small-molecule therapeutics targeting cancer and autoimmune disorders. The company specializes in creating innovative treatments that address unmet medical needs in these critical areas. Through its focused approach, Xanthus Pharmaceuticals aims to advance healthcare solutions that improve patient outcomes and enhance the quality of life for those affected by these diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.